Prof. Bawazir Pharma Consulting Center

Basics of Drug Regulatory Affairs SFDA System Explained Training 9 December 2024 Riyadh
2024-12-09 09:00 - 16:00 (Europe/Moscow) | Bawazir Pharma Office, PJW5+79, Riyadh, 13513, Saudi Arabia
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 6 December 2024.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 9 December 2024 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes used by the Saudi Food and Drug Authority (SFDA) in regulatory submission and approval.
Define official regulatory policies and other issues pertinent to a successful SFDA regulatory strategy.
Describe key differences between National and the Gulf Cooperation Council Drug Registration regulatory requirements.
Describe the requirements for marketing applications for drugs and biologics, New Drug Application (NDA), Biosimilares, Generic drugs, herbal and health products and document preparation.
Recognize SFDA oversight and processes during the post-approval phase.
Interact appropriately with the SFDA during all phases of drug registration
Understand the regulatory requirements for prescription drug labelling and advertising/promotion.

KEY TOPICS

Principals of Regulatory Affairs (RA) and Legal Framework
SFDA overview and pharmaceutical institutions licensing
Principles of Products licensing and Evaluation
GMP Inspection and Products Pricing
Overview of the pharmacovigilance system
Principles of Products Classifications and Listing
Products Import, Release and Advertising
Overview of the SFDA Electronic systems

WHO WILL ATTEND
Professionals working in:

Pharma Regulatory Affairs
Fresh Graduate
Scientific Office Managers
Regulatory Authorities.
Dossier Management
Pharmacist
Compliance

Advance Comprehensive Pharmacovigilance Training 17-18 December 2024 Riyadh
2024-12-17 09:00 - 2024-12-18 16:00
Note: All training programs require physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 16th December, 2024.
SAR 5200.00

OVERVIEW
This two-day course is designed for those who look to increase their knowledge in drug safety and will provide a comprehensive, yet practical assessment of the main regulations required to comply with SFDA regulations.
Download Brochure Advance Comprehensive Pharmacovigilance Training 17-18 December 2024 Riyadh, Saudi Arabia

KEY TOPICS

Pharmacoepidemiological methods
Management of PharmacovigilanceData
Spontaneous Case Processing
Literature searching
Pharmacovigilance methods
Signal detection
Causality assessment

WHO WILL ATTEND
Professionals working in:

QPPV
Pharma Regulatory Affairs
Country Managers
Scientific Office Managers
Contract Research Organizations (CROs)
Regulatory Authorities.
Pharmacist

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate 13-14 January 2025 Riyadh Saudi Arabia
2025-01-13 09:00 - 2025-01-14 16:30
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 11 January 2025.
SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_13-14 January_2025 Riyadh, Saudi Arabia

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes of pharmacovigilance

Define official regulatory policies and other issues pertinent to SFDA Pharmacovigilance System
Describe the component of the PV System
Understand the role and responsibilities of the QPPV
Understand national pharmacovigilance sub-system file (national PSSF)
Recognize SFDA oversight and processes during the post-approval phase.
Understand ADR case assessment, PSUR and risk management.
Interact appropriately with the SFDA regarding PV
Understand the process of PV inspection and audits.

KEY TOPICS

Introduction to Pharmacoepidemiology and Pharmacovigilance
Pharmacovigilance systems and their quality systems
Pharmacovigilance System Master File
Qualified Person Responsible for Pharmacovigilance in Saudi Arabia
Risk Management Systems
Management and Reporting of Adverse Reactions to Medicinal Products
Periodic Safety Update Reports
Post-Authorization Safety Studies
Signal Management
Safety Communication
Risk Minimization Measures
Pharmacovigilance Inspections
Pharmacovigilance Audits
Basic concepts of vaccines and adverse events following immunization

WHO WILL ATTEND
Professionals working in:

QPPV
Pharma Regulatory Affairs
Country Managers
Scientific Office Managers
Contract Research Organizations (CROs)
Regulatory Authorities.
Pharmacist
Compliance

Basics of Drug Regulatory Affairs SFDA System Explained Training 3 February 2025 Riyadh
2025-02-03 09:00 - 16:00
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 30 JANUARY 2025.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.

Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 3 February 2025 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes used by the Saudi Food and Drug Authority (SFDA) in regulatory submission and approval.
Define official regulatory policies and other issues pertinent to a successful SFDA regulatory strategy.
Describe key differences between National and the Gulf Cooperation Council Drug Registration regulatory requirements.
Describe the requirements for marketing applications for drugs and biologics, New Drug Application (NDA), Biosimilares, Generic drugs, herbal and health products and document preparation.
Recognize SFDA oversight and processes during the post-approval phase.
Interact appropriately with the SFDA during all phases of drug registration
Understand the regulatory requirements for prescription drug labelling and advertising/promotion.

KEY TOPICS

Principals of Regulatory Affairs (RA) and Legal Framework
SFDA overview and pharmaceutical institutions licensing
Principles of Products licensing and Evaluation
GMP Inspection and Products Pricing
Overview of the pharmacovigilance system
Principles of Products Classifications and Listing
Products Import, Release and Advertising
Overview of the SFDA Electronic systems

WHO WILL ATTEND
Professionals working in:

Pharma Regulatory Affairs
Fresh Graduate
Scientific Office Managers
Regulatory Authorities.
Dossier Management
Pharmacist
Compliance

Common Technical Documents (CTD) and (eCTD) preparation 10 April 2025 Riyadh
2025-04-10 09:00 - 16:00
Date of training 10 April 2025 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 2500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 7 April 2025.

SAR 1500.00

OVERVIEW
This course will offer insight into the compilation of the eCTDs, share experience and best practices gained during eCTD submissions in the GCC, explain the eCTD review and lifecycle process and the upcoming eCTD requirements.

Advance Regulatory Understanding SFDA Drug Pricing System, Reimbursement and Market Access. 20 April, 2025 Riyadh
2025-04-20 09:00 - 16:00
Note: All training programs require physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 2500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 18 April 2025.

SAR 1500.00

OVERVIEW
The rise in costs of pharmaceutical products in general affects all sectors of the
health care industry, including private insurers and patients. This workshop shall
give an overview on the pricing practices of pharmaceutical products in SFDA and GCC_DR.
In addition, a thorough discussion on the pricing policy by SFDA shall be presented and what you need to learn to price your products.

Download Brochure Advance Regulatory Understanding SFDA Drug Pricing System, Reimbursement and Market Access 20 April 2025 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Understand the history of pharmaceuticals pricing and the different types of pricing modalities.
Understand the principals of SFDA and GCC_DR pricing system.
How to prepare your product pricing certificate. How to predict your product pricing
How to petition pricing decision.

KEY TOPICS

History of Pharmaceuticals pricing.
Modalities of pricing.
Reference pricing and reimbursement.
Pharmacoeconomic.
Pharmaceutical Pricing Policies – Regional Experience
How to prepare your pricing certificate?
How to predict your product price?

WHO WILL ATTEND

Professionals working in:

Healthcare Executives.
Economists.
Pharmaceutical Industry.
Health Insurance Professionals.
Law professionals.
Pharma Regulatory Affairs.
Scientific Office Managers.
Regulatory Authorities.
pharmaceutical manufacturers.
Pharmacist.

Basics of Drug Regulatory Affairs SFDA System Explained Training 18 June 2025 Riyadh
2025-06-18 09:00 - 16:00
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 16 June 2025.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 18 June 2025 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes used by the Saudi Food and Drug Authority (SFDA) in regulatory submission and approval.
Define official regulatory policies and other issues pertinent to a successful SFDA regulatory strategy.
Describe key differences between National and the Gulf Cooperation Council Drug Registration regulatory requirements.
Describe the requirements for marketing applications for drugs and biologics, New Drug Application (NDA), Biosimilares, Generic drugs, herbal and health products and document preparation.
Recognize SFDA oversight and processes during the post-approval phase.
Interact appropriately with the SFDA during all phases of drug registration
Understand the regulatory requirements for prescription drug labelling and advertising/promotion.

KEY TOPICS

Principals of Regulatory Affairs (RA) and Legal Framework
SFDA overview and pharmaceutical institutions licensing
Principles of Products licensing and Evaluation
GMP Inspection and Products Pricing
Overview of the pharmacovigilance system
Principles of Products Classifications and Listing
Products Import, Release and Advertising
Overview of the SFDA Electronic systems

WHO WILL ATTEND
Professionals working in:

Pharma Regulatory Affairs
Fresh Graduate
Scientific Office Managers
Regulatory Authorities.
Dossier Management
Pharmacist
Compliance

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate 7-8 July 2025 Riyadh Saudi Arabia
2025-07-07 09:00 - 2025-07-08 16:30
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 5 July 2025.
SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_7-8 July_2025 Riyadh, Saudi Arabia

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes of pharmacovigilance

Define official regulatory policies and other issues pertinent to SFDA Pharmacovigilance System
Describe the component of the PV System
Understand the role and responsibilities of the QPPV
Understand national pharmacovigilance sub-system file (national PSSF)
Recognize SFDA oversight and processes during the post-approval phase.
Understand ADR case assessment, PSUR and risk management.
Interact appropriately with the SFDA regarding PV
Understand the process of PV inspection and audits.

KEY TOPICS

Introduction to Pharmacoepidemiology and Pharmacovigilance
Pharmacovigilance systems and their quality systems
Pharmacovigilance System Master File
Qualified Person Responsible for Pharmacovigilance in Saudi Arabia
Risk Management Systems
Management and Reporting of Adverse Reactions to Medicinal Products
Periodic Safety Update Reports
Post-Authorization Safety Studies
Signal Management
Safety Communication
Risk Minimization Measures
Pharmacovigilance Inspections
Pharmacovigilance Audits
Basic concepts of vaccines and adverse events following immunization

WHO WILL ATTEND
Professionals working in:

QPPV
Pharma Regulatory Affairs
Country Managers
Scientific Office Managers
Contract Research Organizations (CROs)
Regulatory Authorities.
Pharmacist
Compliance

Basics of Drug Regulatory Affairs SFDA System Explained Training 6 August 2025 Riyadh
2025-08-06 09:00 - 16:00
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 5 August 2025.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 6 August 2025 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes used by the Saudi Food and Drug Authority (SFDA) in regulatory submission and approval.
Define official regulatory policies and other issues pertinent to a successful SFDA regulatory strategy.
Describe key differences between National and the Gulf Cooperation Council Drug Registration regulatory requirements.
Describe the requirements for marketing applications for drugs and biologics, New Drug Application (NDA), Biosimilares, Generic drugs, herbal and health products and document preparation.
Recognize SFDA oversight and processes during the post-approval phase.
Interact appropriately with the SFDA during all phases of drug registration
Understand the regulatory requirements for prescription drug labelling and advertising/promotion.

KEY TOPICS

Principals of Regulatory Affairs (RA) and Legal Framework
SFDA overview and pharmaceutical institutions licensing
Principles of Products licensing and Evaluation
GMP Inspection and Products Pricing
Overview of the pharmacovigilance system
Principles of Products Classifications and Listing
Products Import, Release and Advertising
Overview of the SFDA Electronic systems

WHO WILL ATTEND
Professionals working in:

Pharma Regulatory Affairs
Fresh Graduate
Scientific Office Managers
Regulatory Authorities.
Dossier Management
Pharmacist
Compliance

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate 11-12 August 2025 Riyadh Saudi Arabia
2025-08-11 09:00 - 2025-08-12 16:00
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 9 August 2025.
SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_11-12 August_2025 Riyadh, Saudi Arabia

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes of pharmacovigilance

Define official regulatory policies and other issues pertinent to SFDA Pharmacovigilance System
Describe the component of the PV System
Understand the role and responsibilities of the QPPV
Understand national pharmacovigilance sub-system file (national PSSF)
Recognize SFDA oversight and processes during the post-approval phase.
Understand ADR case assessment, PSUR and risk management.
Interact appropriately with the SFDA regarding PV
Understand the process of PV inspection and audits.

KEY TOPICS

Introduction to Pharmacoepidemiology and Pharmacovigilance
Pharmacovigilance systems and their quality systems
Pharmacovigilance System Master File
Qualified Person Responsible for Pharmacovigilance in Saudi Arabia
Risk Management Systems
Management and Reporting of Adverse Reactions to Medicinal Products
Periodic Safety Update Reports
Post-Authorization Safety Studies
Signal Management
Safety Communication
Risk Minimization Measures
Pharmacovigilance Inspections
Pharmacovigilance Audits
Basic concepts of vaccines and adverse events following immunization

WHO WILL ATTEND
Professionals working in:

QPPV
Pharma Regulatory Affairs
Country Managers
Scientific Office Managers
Contract Research Organizations (CROs)
Regulatory Authorities.
Pharmacist
Compliance

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate 8-9 September 2025 Riyadh Saudi Arabia
2025-09-08 09:00 - 2025-09-09 16:30
FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 6 September 2025.
SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_8-9 September_2025 Riyadh

Basics of Drug Regulatory Affairs SFDA System Explained Training 15 September 2025 Riyadh
2025-09-15 09:00 - 16:00
Note: This training program requires physical presence and will be held in Riyadh at Bawazir Pharma Center

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 12 September 2025.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.

Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 15 September 2025 Riyadh

LEARNING OBJECTIVES
At the conclusion of this training, participants will be able to:

Define the key principles and processes used by the Saudi Food and Drug Authority (SFDA) in regulatory submission and approval.
Define official regulatory policies and other issues pertinent to a successful SFDA regulatory strategy.
Describe key differences between National and the Gulf Cooperation Council Drug Registration regulatory requirements.
Describe the requirements for marketing applications for drugs and biologics, New Drug Application (NDA), Biosimilares, Generic drugs, herbal and health products and document preparation.
Recognize SFDA oversight and processes during the post-approval phase.
Interact appropriately with the SFDA during all phases of drug registration
Understand the regulatory requirements for prescription drug labelling and advertising/promotion.

KEY TOPICS

Principals of Regulatory Affairs (RA) and Legal Framework
SFDA overview and pharmaceutical institutions licensing
Principles of Products licensing and Evaluation
GMP Inspection and Products Pricing
Overview of the pharmacovigilance system
Principles of Products Classifications and Listing
Products Import, Release and Advertising
Overview of the SFDA Electronic systems

WHO WILL ATTEND
Professionals working in:

Pharma Regulatory Affairs
Fresh Graduate
Scientific Office Managers
Regulatory Authorities.
Dossier Management
Pharmacist
Compliance

Basics of Drug Regulatory Affairs SFDA System Explained
2025-11-03 09:00 - 16:00
Date of training 3 November 2025 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 1 November 2025.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 3 November 2025 Riyadh

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate
2025-11-25 09:00 - 2025-11-26 16:00
Date of training 25-26 November 2025 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 24 November 2025.
SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_25-26 November 2025 Riyadh

Basics of Drug Regulatory Affairs SFDA System Explained
2026-01-19 09:00 - 16:00
Date of training 19 January 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 18 January 2026.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 19 January 2026 Riyadh

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate
2026-01-20 09:00 - 2026-01-21 16:00
Date of training 20-21 Januaruy 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 18 Januaruy 2025.

SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_20-21 January_2026 Riyadh

Basics of Drug Regulatory Affairs SFDA System Explained
2026-04-06 09:00 - 16:00
Date of training 6 April 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 3 April 2026.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 6 April 2026 Riyadh

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate
2026-04-07 09:00 - 2026-04-08 16:00
Date of training 7-8 April 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 3 April 2026.

SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_7-8 April_2026 Riyadh

Common Technical Documents (CTD) and (eCTD) preparation
2026-04-09 09:00 - 16:00
Date of training 9 April 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 2900.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 7 April 2026.

SAR 2000.00

OVERVIEW
This course will offer insight into the compilation of the eCTDs, share experience and best practices gained during eCTD submissions in the GCC, explain the eCTD review and lifecycle process and the upcoming eCTD requirements.

Download Brochure Common Technical Documents (CTD) and (eCTD) preparation 9_April_2026 Riyadh

Basics of Drug Regulatory Affairs SFDA System Explained
2026-05-11 09:00 - 16:00
Date of training 11 May 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 3400.00

EARLY BIRD REGISTRATION FEE
PAY YOUR FEE BEFORE 9 MAY 2026.

SAR 2400.00

OVERVIEW
Understanding drug regulatory affairs is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working in the regulatory affairs departments or related fields, who need knowledge of the SFDA regulatory processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, project management and marketing, etc.
Download Brochure Basics of Drug Regulatory Affairs SFDA Explained 11 May 2026 Riyadh

Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate
2026-05-12 09:00 - 2026-05-13 16:00
Date of training 12-13 May 2026 Riyadh Saudi Arabia

FEES
SAUDI RIYAL

REGISTRATION FEES
SAR 6500.00

EARLY BIRDS REGISTRATION FEE
PAY YOUR FEE BEFORE 12 May 2026.

SAR 5200.00

OVERVIEW
Understanding Pharmacovigilance System in Saudi Arabia is very important for persons working in pharmaceutical sector in the region. This course is specifically designed for persons working as Qualified Person of Pharmacovigilance (QPPV) in the regulatory affairs departments or related fields, who need knowledge of the SFDA Pharmacovigilance System and processes. This training will also enhance understanding and be beneficial to persons who work in clinical research, data management, basic research, and marketing, etc.

Download Brochure Comprehensive SFDA Pharmacovigilance System Explained Basic and Intermediate_12-13 May_2026 Riyadh
